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Anesthetics are an indispensable prerequisite for surgical intervention and pharmacological animal studies. 
The objective of present study was to optimize the dose of ketamine (K) and xylazine (X) along with 
atropine sulfate (A) in order to achieve surgical tolerance in BALB/c mice. Several doses of ketamine 
(100, 150, 200 mg/kg) and xylazine (10, 15, 20 mg/kg) were mixed and combination of nine doses 
(K/X: 100/10, 100/15, 100/20, 150/10, 150/15, 150/20, 200/10,200/15,200/20) were evaluated (n=9 
per combination). A constant dose of atropine (0.05 mg/kg) was also used to counter side effect. Time-
related parameters were evaluated on the basis of reflexes. KX at dose 200/20 mg/kg produced surgical 
tolerance in all nine mice with duration 55.00±6.87 minutes. The induction time 0.97±0.09 minutes, 
sleeping time 90.67±5.81 minutes and immobilization time (102.23±6.83 minutes) were significantly 
higher than all combination. However, this combination was considered unsafe due to 11 % mortality. 
While, KX at dose 200/15 mg/kg results in none of the mortality, so was considered as safe. Moreover, 
this combination produces surgical tolerance in 89 % mice with duration (30.00±7.45 minutes). It was 
concluded that KX at dose 200/15 mg/kg along with atropine 0.05 mg/kg is safe for performing surgical 
interventions in BALB/c mice.
Keywords: Ketamine hydrochloride. Xylazine hydrochloride. Atropine sulfate. Surgical tolerance. 
BALB/c mice.
INTRODUCTION
The mouse is regarded as a model animal for 
biomedical research (Popova et al., 2002). Anesthesia in 
the mouse is an indispensable prerequisite for surgical 
interventions as well as pharmacological animal studies 
(Chong et al., 2016). Moreover, an increasing number 
of transgenic mouse models are being explored by the 
scientific community, to evaluate the functional and 
patho-physiological consequences of gene manipulation 
(Zuurbier et al., 2014). Anesthesia usually comprises of 
two or more drugs, because no single drug is consider 
as an ideal for providing anesthesia (Alves et al., 2009; 
Arras et al., 2001). Methods of induction and maintenance 
of anesthesia include gaseous and injectable anesthetics. 
Although gaseous anesthetics provide good control over 
anesthesia depth but equipment cost and lack of skilled 
manpower limit their use (Buitrago et al., 2008).
The selection of anesthetic depends upon drug 
availability, safety, and attainment of surgical tolerance 
(Arras et al., 2001). Surgical tolerance is the stage 
of anesthesia during which animal is completely 
unconscious from surrounding and has no pain perception 
(Arras et al., 2001; Buitrago et al., 2008). This is 
the most significant parameter in the selection of an 
anesthetic during this stage, and surgical interventions 
are performed and duration of surgical interventions 
also depends upon the duration. Mostly dissociative 
drugs (ketamine, K) with α2-agonists (xylazine, X) are 
commonly used for mice (Arras et al., 2001; Chaves, 
Weinstein, Bauer, 2001; Buitrago et al., 2008; Alves et al., 
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2009). But it is documented that, KX at recommended 
doses do not produce surgical tolerance in all animals 
(Arras et al., 2001; Chaves, Weinstein, Bauer, 2001; 
Dittmar et al., 2004; Kawahara et al., 2005; Chu et al., 
2006), therefore, some other drugs are added to produce 
surgical tolerance. In this regard, acepromazine with KX 
is considered as best combination due to its safety and 
surgical tolerance (Arras et al., 2001; Buitrago et al., 
2008). Since acepromazine is not available in the local 
market, an alternate need to be search and various doses 
of KX in conjunction with the new drug need to be 
readjust. 
Anticholinergic drugs such as atropine sulfate 
(A) are commonly used as pre-anesthetic and reduce 
hypersalivation and bradycardia induced by ketamine 
(Wellington, Mikaelian, Singer, 2013). Moreover, atropine 
along with KX is frequently used in veterinary practices 
(Cruz et al., 2000). Therefore, the objective of the present 
study was to select the best dose of KX along with atropine 
that should be safe and produce surgical tolerance for 
performing surgical interventions in BALB/c mouse. 
MATERIAL AND METHODS
Male BALB/c mice at the age of 9-10 weeks, 
maintained at mice housing facility, Department of 
Theriogenology, University of Veterinary and Animal 
Sciences, Lahore, Pakistan were selected. Mice were 
housed in 12 hours dark-light cycles and were cared 
for according to animal protocols approved by the 
ethical committee. All chemicals were of high grade and 
purchased from Sigma-Aldrich.
Experimental design
Three doses (100, 150, 200 mg/kg) of ketamine and 
three doses (10, 15, 20 mg/kg) of xylazine along with 
constant dose (0.05 mg/kg) of atropine sulfate were mixed. 
Total nine combinations (KX: 100/10, 100/15, 100/20, 
150/10, 150/15, 150/20, 200/10, 200/15, 200/20) with 
constant dose of atropine (0.05 mg/kg) were prepared. 
All combinations were diluted in sterile saline and 0.1 
mL per 10 g of body weight was injected intraperitoneally 
(Timeline 1). Once the righting reflex was lost, mice were 
placed on a heated platform and their eyes were lubricated 
with normal saline.
The reflexes monitored were cutaneous reflex 
(CR), tail pinch reflex (TPR), pedal withdrawal reflex 
(PWR), corneal reflex (Cr.R) and righting reflex (RR). 
All reflexes were assessed as described previously (Foote, 
Livingston, 1978; Arras et al., 2001; Buitrago et al., 2008; 
Stoicea et al., 2016). Briefly, the CR was assessed by 
pinching needle at the abdomen. The TPR was monitored 
by pinching at the tip of the tail. For assessing PWR, 
the hind limb was slightly extended and the interdigital 
webbing of the foot firmly was pinched between thumb 
and index finger and this reflex was monitored alternatively 
between the left and right hind limbs. Movement from 
TIME LINE 1 - Experimental Design. A constant dose of atropine (0.05 mg/kg) was added in each combination and n=9 mice per 
each combination were used.
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dorsal to sternal recumbency was considered RR. All these 
reflexes were monitored from loss of RR to spontaneous 
movement at the interval of five minutes. Reflexes were 
monitored by scoring system: 0 (no response), 1 (weak 
response), 2 (moderate response) and 3 (strong response). 
Time-related parameters are demonstrated in timeline 2. 
All parameters were assessed by the same operator to 
reduce variability in the experiment. 
Data analysis
The statistical analyses were performed using 
statistical software SAS Enterprise Guide (version 4.2; 
SAS Inst. Inc., Cary NC, USA) and statistical significance 
was set at p<0.05. Data for all parameters were presented 
as mean ± S.E.M. The means were separated using Tukey’s 
test. Data for three doses of two anesthetic groups were 
analyzed as 3 x 3 factorial model using Proc Mixed 
procedure of SAS. The groups were separated using 
pdmix800 utility. Chi-square test was used for analyses of 
the number of mice attaining surgical tolerance.
RESULTS AND DISCUSSION
All doses of ketamine and xylazine along with 
atropine were evaluated for their safety on the basis of 
mice attaining surgical tolerance and death rate. The 
surgical tolerance (Table I) showed that highest dose of 
KX (200/20 mg/kg) produced surgical tolerance in all 
nine mice with maximum duration 55.00±6.87 minutes 
and 11 % death rate (1/9). While 200/15 mg/kg KX 
produced surgical tolerance in eight mice without any 
death. Hence 200/15 mg/kg KX was consider as a 
safe. Furthermore, induction time at 200/15 mg/kg KX 
was comparable  wi th  a l l  combinat ions  except 
100/10, 100/20 mg/kg KX. However, the duration of 
immobilization (102.23±6.83 minutes) and surgical 
tolerance (55.00±6.87 minutes) at 200/20 mg/kg KX was 
significantly higher from other combinations. Similarly, 
the sleeping time at KX (200/20 mg/kg) was significantly 
higher than other combinations except KX (200/10 mg/kg). 
While the recovery period at KX (200/15 mg/kg) was 
comparable with all combination. When the duration of 
different reflexes was analyzed, the duration of PWR, CR, 
TPR, Cr.R, and TS at KX (200/20 mg/kg) was significantly 
higher (Table II) than other combinations. Duration for the 
onset of different reflexes (Table III) represented that onset 
of CR, Cr.R, and TS was quick in KX (200/20 mg/kg) 
as compared to other combination suggesting that the onset 
of these reflexes result after injecting anesthesia. However, 
the onset of PWR and TPR in KX (200/20 mg/kg) were 
comparable with others.
Time Definition Intervals
T0 Time of injection T0-T1—Induction Time
T1 Loss of righting reflex T1-T3—Immobilization
T2 Loss of motion T1-T4—Sleeping Time
T3 Spontaneous Movement T3-T4—Recovery Period
T4 Regain of righting reflex
TIME LINE 2 - Time related parameters
TABLE I - Comparison of safety, efficacy and time related parameters using different doses of ketamine/xylazine in BALB/c mouse
Anesthetic* 
(mg/kg)
Ketamine 100 
Xylazine  10
Ketamine 100 
Xylazine   15
Ketamine 100 
Xylazine   20
Ketamine 150 
Xylazine   10
Ketamine 150 
Xylazine   15
Ketamine 150 
Xylazine   20
Ketamine 200 
Xylazine   10
Ketamine 200 
Xylazine   15
Ketamine 200 
Xylazine   20
Safety margin
Surgical 
tolerance
5/9a 5/9 a 3/9 ab 6/9 a 5/9 a 3/9 a 7/9b 8/9 b 9/9 b
Death rate 0/9 0/9 0/9 0/9 0/9 0/9 0/9 0/9 1**/9
Time related parameters (minutes)
Induction Time 2.17±0.41a 1.62±0.28abc 1.77±0.29ab 1.50±0.13bcd 1.47±0.08 bcd 1.38±0.16 bcd 1.43±0.10 bcd 1.04±0.17 cd 0.97±0.09 cd
Immobilization 49.68±6.46a 55.00±5.33ab 49.40±4.94b 67.83±6.24ab 54.31±5.07ab 77.27±14.10b 83.25±6.48b 66.87±12.47ab 102.23±6.83c
Duration 
of Surgical 
Tolerance
15.00±5.8ab 11.66±4.78b 6.66±4.16b 18.33±7.12ab 18.33±6.87ab 8.33±4.48b 19.44±6.37ab 30.00±7.45a 55.00±6.87c
Sleeping Time 41.69±5.79a 49.20±4.01ab 41.77±4.46a 56.69±4.96abc 48.88±4.25ab 64.10±12.27ab 65.35±5.86cd 55.05±10.96abc 90.67±5.81d
Recovery 
period
7.90±2.02ab 10.25±2.69ab 7.62±1.51ab 11.13±1.97abc 5.44±1.20a 12.92±3.36ac 18.12±3.82c 11.85±3.38abc 11.55±2.22abc
Data are presented as mean ± SD, *Dose of atropine sulfate in all combination was constant (0.05 mg/kg), Number ofmice in each group were constant (n= 9), 
Depth and quality of anesthesia was characterized by use of reflex test and  response to different stimuli, **one mouse died during anesthesia, a-d denote significant 
difference (p<0.05) within row. Values with same letters denote non-significant difference (p> 0.05).
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TABLE II - Comparison of duration of various reflexes using different doses of ketamine/xylazine in BALB/c mouse
Anesthetic* 
(mg/kg)
Ketamine 100 
Xylazine  10
Ketamine 100 
Xylazine   15
Ketamine 100 
Xylazine   20
Ketamine 150 
Xylazine   10
Ketamine 150 
Xylazine   15
Ketamine 150 
Xylazine   20
Ketamine 200 
Xylazine   10
Ketamine 200 
Xylazine   15
Ketamine 200 
Xylazine   20
Duration of various reflexes
Pedal 
withdrawal 
15.00±5.83ab 11.67±4.79b 6.67±4.17b 18.33±7.12ab 18.33±7.12ab 8.33±4.49b 19.44±6.37ab 30.00±7.45a 55.00±6.87c
Cutaneous 36.11±5.45a 46.11±5.51abc 39.44±5.10ac 59.44±4.67b 45.56±4.20abc 58.33±10.47bc 65.00±7.02bd 50.00±9.86abc 82.78±7.46d
Tail pinch 27.22±5.66a 27.78±5.53a 30.56±5.56a 49.44±4.75b 33.89±3.98ab 36.67±8.98ab 45.56±5.49ab 45.56±9.73ab 72.78±7.51c
Corneal 33.33±5.27a 43.33±5.46ab 35.56±5.10a 56.11±5.19b 41.67±3.54ab 59.44±10.78b 60.56±6.74b 49.44±10.32ab 82.78±7.46c
Tactile stimuli 37.78±5.47a 46.11±5.51ab 41.11±4.98ab 59.44±4.67bc 46.11±4.39ab 60.56±11.07bc 67.78±7.17cd 53.33±10.77abc 82.78±7.46d
Data are shown as mean ± SD, All reflexes were monitored after loss of righting reflex till spontaneous movement at 5 minute interval, *Dose of atropine sulfate in 
all combination was constant (0.05 mg/kg) Number of mice in each group were constant (n= 9), Depth and quality of anesthesia was characterized by use of reflex 
test and response to different stimuli,  a-d denote significant difference (p<0.05) within row. Values with same letters denote non-significant difference (p> 0.05).
TABLE III - Comparison of onset of various reflexes of anesthesia using different doses of ketamine/xylazine in mouse
Anesthetic* 
(mg/kg)
Ketamine 100 
Xylazine  10
Ketamine 100 
Xylazine   15
Ketamine 100 
Xylazine   20
Ketamine 150 
Xylazine   10
Ketamine 150 
Xylazine   15
Ketamine 150 
Xylazine   20
Ketamine 200 
Xylazine   10
Ketamine 200 
Xylazine   15
Ketamine 200 
Xylazine   20
Onset of various reflexes
Pedal 
withdrawal 
8.50±1.70abc 7.50±1.58abc 7.50±2.50abc 6.50±2.18bc 5.00±1.58c 14.17±0.83a 10.94±2.16ab 4.69±1.37c 6.11±2.13c
Cutaneous 0.50±0.50ab 1.00±0.61abc 1.67±0.83ac 0.50±0.50ab 0.83±0.53abc 1.67±0.83ac 1.88±0.41c 0.63±0.41ab 0.00±0.00b
Tail pinch 2.50±0.00a 3.00±0.50ab 2.50±0.00abc 2.50±0.00a 3.33±0.83ab 4.17±0.83b 2.50±0.00a 1.25±0.47c 2.22±0.28ac
Corneal 2.50±0.00a 2.00±0.50ab 2.50±0.00a 2.50±0.00a 2.50±0.00a 2.50±0.00a 2.50±0.00a 1.25±0.47b 0.28±0.28c
Tactile stimuli 0.00±0.00 1.00±0.61a 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00
Data are shown as mean ± SD, All reflexes were monitored after loss of righting reflex till spontaneous movement at 5 minute 
interval The data demonstrate that onset of pedal withdrawal reflex was late as compared to other reflexes, *Dose of atropine sulfate 
in all combination was constant (0.05 mg/kg). Number of mice in each group were constant (n= 9),  a-d denote significant difference 
(p<0.05) within row. Values with same letters denote non-significant difference (p> 0.05).
The significance of an anesthetic depend on 
safety and efficacy which is evaluated on the basis of 
mortality rate and surgical tolerance (Arras et al., 2001). 
In the present study, the attainment of this stage was 
observed in dose-dependent manner. Five mice (out of 
nine) attained at the lowest dose (KX: 100/15 mg/kg) 
and all mice (9/9) attained at the highest dose (KX: 
200/20 mg/kg). The duration of surgical tolerance was also 
dose-dependent. The lowest dose of KX (100/10 mg/kg) 
produce 15.00±5.8 minutes while the highest dose 
(200/20 mg/kg KX) produce 55.00±6.87 minutes. 
However, some variations were observed at dose 100/20 
KX and 150/20 mg/kg KX as only three mice (3/9) 
attained tolerance with low duration (Table I). Similar 
variations about KX are already reported (Green et al., 
1981). The possible reason for such variability are mouse 
age, nutrition, and liver metabolism. It is documented that 
short-term fasting before anesthesia leads to increase drug 
metabolism resulting in decrease response. Moreover, 
failure of injection site (injection into muscle or sub cut 
tissue instead of peritoneum) may be another contributing 
factor because up to 20% failure rate had been reported 
(Struck et al., 2011).
The data for mortality rate revealed that all doses 
of KX are safe for mouse except the highest one 
(KX: 200/20 mg/kg) as one mouse (1/9) was found 
dead at this dose (Table I). The death may be due to 
hypotension (Picollo et al., 2012), cardiac arrhythmias 
and hypersalivation (Green et al., 1981) produced by KX. 
These findings were not in line with previous studies where 
it was reported that KX caused significant mortalities at the 
recommended dose. The decreased mortality could be due 
to the addition of the anticholinergic drug, atropine sulfate 
as it subsides cardiac dysfunctions and hypersalivation. 
Moreover, atropine produces sedation by crossing blood 
brain-barrier (Lu et al., 2014) and also increase the 
sleeping time (Foote, Livingston, 1978). Furthermore, age, 
sex, genetic and environmental factors as well as inherent 
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inter-individual variability might have contributed to 
anesthetic variability (Struck et al., 2011). 
The purpose of anesthesia is analgesia and 
unconsciousness. Different reflexes such as cutaneous 
reflex, tail pinch reflex, pedal withdrawal reflex, corneal 
reflex and tactile stimuli (Green et al., 1981; Arras et al., 
2001) were used for pain perception and anesthesia depth. 
The onset of all reflexes revealed that PWR disappeared 
later and re-appeared earlier than other reflexes (Table III). 
Although cutaneous reflex, tail pinch reflex, tactile 
stimulus were also used for pain perception, their onset 
was earlier and remained absent while PWR was still 
present. Hence, PWR is the best indicator of anesthetic 
depth as it disappears later and reappears earlier than all 
other reflexes (Arras et al., 2001; Buitrago et al., 2008; 
Alves et al., 2009; Struck et al., 2011). The duration of loss 
of PWR was increased with dose and maximum duration 
(55.00±6.87 minutes) was observed at the highest dose 
(KX: 200/20 mg/kg) (Table II). However, the duration 
was compromised at (KX: 100/20, 150/20 mg/kg). This 
may be due to the decrease in response of mice attaining 
surgical tolerance (Table I). Moreover, inter-individual 
variations are also reported at same dose. The duration of 
PWR revealed that KX: 200/20 mg/kg is the best than all 
other doses as it produces 55.00±6.87 minutes anesthesia. 
On the basis of attainment of surgical tolerance, 
and loss of reflexes although KX; 200/20 mg/kg was the 
best for surgical interventions but one mouse (1/9) was 
found dead which render this dose unsafe to be used as 
anesthesia. While KX: 200/15 mg/kg was considered safe 
as no mouse found dead (Table I). Moreover, this dose 
produces surgical tolerance of 30.00±7.45 minutes. This 
dose was considered best for surgical intervention. 
Best anesthetic is one which has minimum induction, 
acceptable surgical tolerance and quick recovery with no 
mortalities. The dose (KX: 200/15 mg/kg) has the similar 
response like low induction time (1.04±0.17 minutes) 
with the surgical tolerance of 30 minutes. Moreover, the 
recovery period was minimized (11.85±3.3 minutes) 
without mortality (Table I). However, some surgeons 
prefer anesthetic with minimum duration to potentiate 
their efficiency so they use lower doses of anesthetics. 
Although minimum duration was achieved at lower doses 
(KX: 100/10 mg/kg) but the number of mice attaining 
surgical tolerance were compromised (5/9). Furthermore, 
the variability of the individual mouse to same anesthetic 
dose revealed that there is no standard anesthetic 
combination as there is no standard mouse (Arras et al., 
2001; Zuurbier et al., 2014). So, each laboratory maintain 
own standard according to experimental design. Hence, 
KX (200/15mg/kg) was suggested to be the best dose.
It is acknowledged that KX with acepromazine 
is considered suitable for the mouse but in the present 
study, we reported first time that KX along with 
atropine is also suitable combination to produce surgical 
tolerance without significant mortalities. Present study 
results were comparable to previous reports as KX 
with acepromazine produces surgical tolerance in 
85% mice (17/20) (Arras et al., 2001) while KX with 
atropine result in surgical tolerance in 88 % mice (8/9). 
Moreover, induction time, immobilization, duration 
of surgical tolerance and recovery periods were also 
comparable to KX with acepromazine (Arras et al., 2001; 
Buitrago et al., 2008). 
 It is concluded that ketamine: xylazine along with 
atropine at dose rate 200/15/0.05 mg/kg is suitable for 
surgical interventions in BALB/c mouse. However, further 
studies should be conducted to observe cardiac dynamics 
and physiological parameters for this combination. 
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